Vapogenix Garners $7,978,130 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    8285 El Rio St. Houston, TX 77054 USA
  • Company Description
    Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 35 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy